Phase II trial of trimetrexate in patients with advanced renal cell carcinoma. Clinical Community Oncology Program.
Sternberg
C N
CN
Memorial Sloan-Kettering Cancer Center, Solid Tumor Service, New York, NY 10021.
Yagoda
A
A
Scher
H
H
Bosl
G
G
Dershaw
D
D
Rosado
K
K
Houston
C
C
Rosenbluth
R
R
Vinciguerra
V
V
Boselli
B
B
D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D004341:Drug Evaluation; D005493:Folic Acid Antagonists / Q000627:therapeutic use; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008875:Middle Aged; D011799:Quinazolines / Q000627:therapeutic use*; D016597:Trimetrexate
D000970:Antineoplastic Agents; D005493:Folic Acid Antagonists; D011799:Quinazolines; D016597:Trimetrexate